SunWay Biotech and Gnosis by Lesaffre have partnered to create a new ingredient, MenaQ7 Metabolic, featuring the former company’s Ankascin 568-R ingredient.
 
The new ingredient, which debuted at Expo West, combines vitamin K2 as MK-7 and Ankascin 568-R, a red yeast rice fermentation material that doesn’t contain Monacolin K (statin) which has achieved New Dietary Ingredient (NDI) status. The latter ingredient has been supported by over 130 scientific publications supporting its beneficial role in various metabolic issues.
 
“Gnosis’ global presence ensures close collaboration with our clients worldwide,” said Julie Lemahieu, markets and solutions director at Gnosis by Lesaffre.
 
“Sunway Biotech is committed to enhancing human health through advanced biological transformation processes. By leveraging unique fermentation technology, SunWay maximizes the commercial value of natural functional ingredients and maintains its industry-leading position through continuous expansion of its strain library and optimization of fermentation core technology. We are honored to partner with Gnosis by Lesaffre, a key global player in fermentation. Sunway looks forward to supporting quality and unique ingredients to global nutraceuticals.